UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease

Expert review of vaccines, 2018-09, Vol.17 (9), p.819-831

2018

Link zum Volltext

Verfügbarkeit prüfen

Glycan‐masking hemagglutinin antigens from stable CHO cell clones for H5N1 avian influenza vaccine development

Biotechnology and bioengineering, 2019-03, Vol.116 (3), p.598-609

2019

Link zum Volltext

Verfügbarkeit prüfen

Identification and characterization of a cross-neutralization epitope of Enterovirus 71

Vaccine, 2011-06, Vol.29 (26), p.4362-4372

2011

Link zum Volltext

Verfügbarkeit prüfen

Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development

Vaccine, 2019-11, Vol.37 (47), p.6933-6941

2019

Link zum Volltext

Verfügbarkeit prüfen

Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system

PloS one, 2011-05, Vol.6 (5), p.e20005-e20005

2011

Link zum Volltext

Verfügbarkeit prüfen

Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71

PloS one, 2013-02, Vol.8 (2), p.e57591-e57591

2013

Link zum Volltext

Verfügbarkeit prüfen

Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers

PloS one, 2013-11, Vol.8 (11), p.e79783-e79783

2013

Link zum Volltext

Verfügbarkeit prüfen

The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage

Journal of microbiology, immunology and infection, 2023-12, Vol.56 (6), p.1121-1128

2023

Link zum Volltext

Verfügbarkeit prüfen

Caveolar Endocytosis Is Required for Human PSGL-1-Mediated Enterovirus 71 Infection

Journal of Virology, 2013-08, Vol.87 (16), p.9064-9076

2013

Link zum Volltext

Verfügbarkeit prüfen

A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine

Vaccine, 2013-05, Vol.31 (20), p.2471-2476

2013

Link zum Volltext

Verfügbarkeit prüfen

Heat shock protein 90: role in enterovirus 71 entry and assembly and potential target for therapy

PloS one, 2013-10, Vol.8 (10), p.e77133

2013

Link zum Volltext

Verfügbarkeit prüfen

Mutations in VP1 and 5'-UTR affect enterovirus 71 virulence

Scientific reports, 2018-04, Vol.8 (1), p.6688-11, Article 6688

2018

Link zum Volltext

Verfügbarkeit prüfen

Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture

Vaccine, 2018-05, Vol.36 (22), p.3134-3139

2018

Link zum Volltext

Verfügbarkeit prüfen

Immunological and biochemical characterization of coxsackie virus A16 viral particles

PloS one, 2012-11, Vol.7 (11), p.e49973

2012

Link zum Volltext

Verfügbarkeit prüfen

The uncoating of EV71 in mature late endosomes requires CD-M6PR

Biology open, 2022-09, Vol.11 (9)

2022

Link zum Volltext

Verfügbarkeit prüfen

Human SCARB2-mediated entry and endocytosis of EV71

PloS one, 2012-01, Vol.7 (1), p.e30507-e30507

2012

Link zum Volltext

Verfügbarkeit prüfen

Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases

Vaccine, 2014-10, Vol.32 (47), p.6177-6182

2014

Link zum Volltext

Verfügbarkeit prüfen

Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates

PloS one, 2012-04, Vol.7 (4), p.e34834-e34834

2012

Link zum Volltext

Verfügbarkeit prüfen

Review of Enterovirus 71 Vaccines

Clinical infectious diseases, 2015-03, Vol.60 (5), p.797-803

2015

Link zum Volltext

Verfügbarkeit prüfen

Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies

Expert opinion on drug discovery, 2022-01, Vol.17 (1), p.27-39

2022

Link zum Volltext

Verfügbarkeit prüfen

Selection and characterization of vaccine strain for Enterovirus 71 vaccine development

Vaccine, 2012-01, Vol.30 (4), p.703-711

2012

Link zum Volltext

Verfügbarkeit prüfen

Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice

PloS one, 2013-07, Vol.8 (7), p.e69858-e69858

2013

Link zum Volltext

Verfügbarkeit prüfen

Production of EV71 vaccine candidates

Human vaccines & immunotherapeutics, 2012-12, Vol.8 (12), p.1775-1783

2012

Link zum Volltext

Verfügbarkeit prüfen

Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease

PLoS neglected tropical diseases, 2015-04, Vol.9 (4), p.e0003692-e0003692

2015

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity Studies of Bivalent Inactivated Virions of EV71/CVA16 Formulated with Submicron Emulsion Systems

BioMed research international, 2014-01, Vol.2014, p.670506-8

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease

Glycan‐masking hemagglutinin antigens from stable CHO cell clones for H5N1 avian influenza vaccine development

Identification and characterization of a cross-neutralization epitope of Enterovirus 71

Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development

Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system

Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71

Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers

The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage

Caveolar Endocytosis Is Required for Human PSGL-1-Mediated Enterovirus 71 Infection

A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine

Heat shock protein 90: role in enterovirus 71 entry and assembly and potential target for therapy

Mutations in VP1 and 5'-UTR affect enterovirus 71 virulence

Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture

Immunological and biochemical characterization of coxsackie virus A16 viral particles

The uncoating of EV71 in mature late endosomes requires CD-M6PR

Human SCARB2-mediated entry and endocytosis of EV71

Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases

Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates

Review of Enterovirus 71 Vaccines

Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies

Selection and characterization of vaccine strain for Enterovirus 71 vaccine development

Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice

Production of EV71 vaccine candidates

Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease

Immunogenicity Studies of Bivalent Inactivated Virions of EV71/CVA16 Formulated with Submicron Emulsion Systems

Suchergebnisse filtern